Leafy green vegetables

Leafy green vegetables has been studied in 1 paper since 2021: 1 observational study in people. The newest paper, Sep 10, 2021: “Mediterranean diet, walking outdoors and polypharmacy in older patients with type II diabetes”.

Exposure

1 paper studies it1 findingUpdated

See all 1 papers on leafy green vegetables

At a glance

The findings reach people, from one lab or study. 1 lab in 1 country.

“leafy green vegetables (OR: 0.54, 95% CI: 0.33-0.87; P-trend = 0.013)”
Mediterranean diet, walking outdoors and polypharmacy in older patients with type II diabetesEuropean journal of public health2021doi:10.1093/eurpub/ckab113
Humans: a single group. Cells, worms or flies and mice: nothing yet.
  • 1 lab in 1 country
  • Humans1

What did studies of leafy green vegetables find?

1

Studies of leafy green vegetables measured one outcome, Comorbidity-Polypharmacy Score.

Comorbidity-Polypharmacy Score

downin humans1OR 0.54

1 study
  1. Leafy green vegetables are linked with lower Comorbidity-Polypharmacy Score in humans (adjusted for age, sex, body mass index, physical activity and cognitive status) (OR 0.54, 95% CI 0.33-0.87).

    Humansadjusted for age, sex, body mass index, physical activity and cognitive status

More on Comorbidity-Polypharmacy Score

Latest